In a 5 years’ cohort study involving 1.103 Thai patients it was shown that genetic screening can predict adverse effects (skin and mucous membrane irritations).
RIKEN press release, July 3, 2013
RIKEN and Thai Mahidol University establish genetic screening for adverse effects of Nevirapine treatment of AIDS patients (GENPART study)